Gerald W Dorn, II, MD
Year elected: 1998
Current membership category: Senior
Washington University School of Medicine
Center for Pharmacogenomics
660 S Euclid Ave, Box 8220
St. Louis, MO 63110
United States of America
Phone: 314 362-4892
Facsimile: 314 362-8844

Biographical statement

The general theme of the Dorn laboratory revolves around how neurohormonal stimulation of the heart contributes to development of cardiac hypertrophy and its progression to heart failure. Our team uses cell and molecular biology platforms to address mechanistic questions relating to receptor-effector coupling, genetically manipulated mice to define functional relevance of signaling pathways in the integrated cardiovascular system, and human genomics that bridge the bench and bedside. Current translational projects investigate how adrenergic receptor desensitization by G-protein receptor kinases affects the stressed or failing heart, and how regulated expression of cardiac microRNAs compensates for myocardial disease. Basic investigations examine novel mechanisms of apoptotic and non-apoptotic programmed cell death by Bcl2-family proteins, and how cardiac injury is mediated by calpain-mediated proteolytic processing of protein kinase C. The laboratory has special expertise in genetic manipulation of mouse hearts using conditional gene ablation and overexpression approaches, and in microsurgical modeling and analytical techniques.

Institutional affiliations

Washington University School of Medicine in St. Louis (Primary)
Deborah J. Veis, MD, PhD is the representative at this institution.


Cardiovascular Disease
General Medicine
Molecular Biology

Positions held

Division/Section Chair
Section Chief
Laboratory Director
Professor, Associate
Research Director
Dean, Associate